| Version |
2.5 |
| Creation Date |
2006-08-16 15:44:11 |
| Update Date |
2009-05-05 20:58:46 |
| Accession Number |
HMDB01419 |
| Secondary Accession Numbers |
Not Available |
| Common Name |
24-Hydroxycholesterol |
| Description |
24-Hydroxycholesterol (24OHC) is almost exclusively formed in the brain. The enzymatic conversion of CNS cholesterol to 24OHC, which readily crosses the blood-brain barrier, is the major pathway for brain cholesterol elimination and brain cholesterol homeostasis maintenance. The enzyme mediating this conversion has been characterized at the molecular level as cholesterol 24-hydroxylase (EC 1.14.13.98, CYP46) and is mainly located in neurons. Like other oxysterols, 24OHC is efficiently converted into normal bile acids or excreted in bile in its sulfated and glucuronidated form. Levels of 24OHC in the circulation decrease with age in infants and children. In adults, however, the levels appear to be stable. There is accumulating evidence pointing toward a potentially important link between cholesterol, beta-amyloid, and Alzheimer's disease. Patients with active demyelinating diseases had increased levels of 24OHC in cerebrospinal fluid (CSF). Patients with Alzheimer's disease have slightly increased levels of 24OHC in CSF. Patients with multiple sclerosis have a tendency to have higher levels of 24OHC during active periods. (PMID: 15061359, 14574622) |
| Synonyms |
- (24S)-24-Hydroxycholesterol
- 24(S)-Hydroxycholesterol
- 24-Hydroxycholesterol
- 24S-Cholest-5-ene-3b,24-diol
- Cerebrosterin
- Cerebrosterol
- Cholest-5-ene-3b,24b-diol
- 24S-hydroxycholesterol
- (24S)-cholest-5-ene-3b,24-diol
- (24S)-cholest-5-ene-3beta,24-diol
- Cholest-5-ene-3,24-diol
- Cholest-5-en-3b,24S-diol
- Cholest-5-en-3beta,24S-diol
|
| Chemical IUPAC Name |
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-hydroxy-6-methyl-heptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol |
| Chemical Formula |
C27H46O2 |
| Chemical Structure |
 |
| Chemical Taxonomy |
| Kingdom |
|
| Super Class |
- Cholesterols and derivatives
|
| Class |
- Steroids and Steroid Derivatives
|
| Sub Class |
|
| Family |
|
| Species |
|
| Biofunction |
- Hormones, Membrane component
|
| Application |
| — |
| Source |
|
|
| Average Molecular Weight |
402.653 |
| Monoisotopic Molecular Weight |
402.349792 |
| Isomeric SMILES |
CC(C)[C@@H](O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C |
| Canonical SMILES |
CC(C)C(O)CCC(C)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C |
| KEGG Compound ID |
C13550  |
| BioCyc ID |
CPD-7239  |
| BiGG ID |
2197434  |
| Wikipedia Link |
Not Available |
| NuGOwiki Link |
HMDB01419  |
| Metagene Link |
HMDB01419  |
| METLIN ID |
Not Available |
| PubChem Compound |
121948  |
| PubChem Substance |
7846926  |
| ChEBI ID |
34310  |
| CAS Registry Number |
474-73-7 |
| InChI Identifier |
InChI=1/C27H46O2/c1-17(2)25(29)11-6-18(3)22-9-10-23-21-8-7-19-16-20(28)12-14-26(19,4)24(21)13-15-27(22,23)5/h7,17-18,20-25,28-29H,6,8-16H2,1-5H3/t18-,20+,21+,22-,23+,24+,25+,26+,27-/m1/s1 |
| Synthesis Reference |
Prasad V V; Ponticorvo L; Lieberman S Identification of 24-hydroxycholesterol in bovine adrenals in both free and esterified forms and in bovine brains as its sulfate ester. Journal of steroid biochemistry (1984), 21(6), 733-6. |
| Melting Point (Experimental) |
Not Available |
| Experimental Water Solubility |
Not Available
Source: PhysProp
|
| Predicted Water Solubility |
4.03e-04 mg/mL [Predicted by ALOGPS]
Calculated using ALOGPS
|
| Physiological Charge |
0 |
| State |
Solid |
| Experimental LogP/Hydrophobicity |
Not Available
Source: PhysProp
|
| Predicted LogP/Hydrophobicity |
6.5 [Predicted by PubChem via XLOGP]; 5.70 [Predicted by ALOGPS]
Calculated using ALOGPS
|
| Material Safety Data Sheet (MSDS) |
Not Available |
| MOL File |
Show |
| SDF File |
Show |
| PDB File |
Show |
| 2D Structure |
|
| 3D Structure |
|
| Experimental PDB ID |
Not Available |
| Experimental 1H NMR Spectrum |
Not Available |
| Experimental 13C NMR Spectrum |
Not Available |
| Experimental 13C HSQC Spectrum |
Not Available |
| Predicted 1H NMR Spectrum |
Show Image Show Peaklist
|
| Predicted 13C NMR Spectrum |
Show Image Show Peaklist
|
| Mass Spectrum |
Not Available |
| Simplified TOCSY Spectrum |
Not Available |
| BMRB Spectrum |
Not Available |
| Cellular Location |
|
| Biofluid Location |
- Blood
- Cerebrospinal Fluid
|
| Tissue Location |
Not Available |
| Concentrations (Normal) |
| Biofluid |
Blood |
| Value |
0.0018 +/- 0.00052 uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Holdenrieder S, Lutjohann D, Geiger S, von Bergmann K, Stieber P, Hamann GF: Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke? Neurosci Lett. 2004 Sep 23;368(2):201-4. [PubMed
]
|
| Biofluid |
CSF |
| Value |
0.0034 (0.0033-0.0036) uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
|
| Concentrations (Abnormal) |
| Biofluid |
Blood |
| Value |
0.11 +/- 0.03 uM |
| Age |
Adult:>18 yrs old |
| Sex |
N/A |
| Condition |
Hypercholesterolemia |
| Comments |
Moderately elevated plasma cholesterol levels |
| References |
- Thelen KM, Laaksonen R, Paiva H, Lehtimaki T, Lutjohann D: High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. J Clin Pharmacol. 2006 Jul;46(7):812-6. [PubMed
]
|
| Biofluid |
CSF |
| Value |
0.0061 (0.0058-0.0064) uM |
| Age |
Elderly:>65 yrs old |
| Sex |
Both |
| Condition |
Alzheimer's disease |
| Comments |
Not Available |
| References |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
| Biofluid |
CSF |
| Value |
0.016 (0.014-0.017) uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Condition |
Demyelinating polyneuropathy |
| Comments |
Not Available |
| References |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
| Biofluid |
CSF |
| Value |
0.0045 (0.0041-0.0050) uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Condition |
Subarachnoid hemorrhage |
| Comments |
Not Available |
| References |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
| Biofluid |
CSF |
| Value |
0.0086 (0.0076-0.0096) uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Condition |
Meningitis |
| Comments |
Viral |
| References |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
| Biofluid |
CSF |
| Value |
0.0062 (0.0057-0.0068) uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Condition |
Neuroborreliosis |
| Comments |
Not Available |
| References |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
| Biofluid |
CSF |
| Value |
0.0077 (0.0066-0.0093) uM |
| Age |
Adult:>18 yrs old |
| Sex |
N/A |
| Condition |
Mild cognitive impairment |
| Comments |
Also known as incipient dementia or isolated memory impairment |
| References |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
| Biofluid |
CSF |
| Value |
0.004 +/- 0.0013 uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Condition |
Multiple sclerosis |
| Comments |
Not Available |
| References |
- Leoni V, Lutjohann D, Masterman T: Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis. J Lipid Res. 2005 Feb;46(2):191-5. Epub 2004 Dec 1. [PubMed
]
|
|
| Associated Disorders |
| Condition |
References |
| Alzheimer's disease |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
| Demyelinating polyneuropathy |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
| Hypercholesterolemia |
- Thelen KM, Laaksonen R, Paiva H, Lehtimaki T, Lutjohann D: High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. J Clin Pharmacol. 2006 Jul;46(7):812-6. [PubMed
]
|
| Meningitis |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
| Mild cognitive impairment |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
| Multiple sclerosis |
- Leoni V, Lutjohann D, Masterman T: Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis. J Lipid Res. 2005 Feb;46(2):191-5. Epub 2004 Dec 1. [PubMed
]
|
| Neuroborreliosis |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
| Subarachnoid hemorrhage |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
|
| OMIM ID |
|
| Pathways |
|
| General References |
- Leoni V, Masterman T, Mousavi FS, Wretlind B, Wahlund LO, Diczfalusy U, Hillert J, Bjorkhem I: Diagnostic use of cerebral and extracerebral oxysterols. Clin Chem Lab Med. 2004 Feb;42(2):186-91. [PubMed
]
|
| Metabolic Enzymes |
- Cytochrome P450, family 39, subfamily A, polypeptide 1
- Cytochrome P450 46A1
|
|
Enzyme 1
[top]
|
| Enzyme 1 ID |
8685 |
| Enzyme 1 Name |
Cytochrome P450, family 39, subfamily A, polypeptide 1 |
| Enzyme 1 Synonyms |
Not Available |
| Enzyme 1 Gene Name |
CYP39A1 |
| Enzyme 1 Protein Sequence |
>Cytochrome P450, family 39, subfamily A, polypeptide 1
MELISPTVIIILGCLALFLLLQRKNLRRPPCIKGWIPWIGVGFEFGKAPLEFIEKARIKY
GPIFTVFAMGNRMTFVTEEEGINVFLKSKKVDFELAVQNIVYRTASIPKNVFLALHEKLY
IMLKGKMGTVNLHQFTGQLTEELHEQLENLGTHGTMDLNNLVRHLLYPVTVNMLFNKSLF
STNKKKIKEFHQYFQVYDEDFEYGSQLPECLLRNWSKSKKWFLELFEKNIPDIKACKSAK
DNSMTLLQATLDIVETETSKENSPNYGLLLLWASLSNAVPVAFWTLAYVLSHPDIHKAIM
EGISSVFGKAGKDKIKVSEDDLENLLLIKWCVLETIRLKAPGVITRKVVKPVEILNYIIP
SGDLLMLSPFWLHRNPKYFPEPELFKPERWKKANLEKHSFLDCFMAFGSGKFQCPARWFA
LLEVQMCIILILYKYDCSLLDPLPKQSYLHLVGVPQPEGQCRIEYKQRI
|
| Enzyme 1 Number of Residues |
469 |
| Enzyme 1 Molecular Weight |
54116 |
| Enzyme 1 Theoretical pI |
8.88 |
| Enzyme 1 GO Classification |
| Function |
- binding
- catalytic activity
- cation binding
- heme binding
- ion binding
- iron ion binding
- monooxygenase activity
- oxidoreductase activity
- tetrapyrrole binding
- transition metal ion binding
|
| Process |
- cellular metabolism
- electron transport
- generation of precursor metabolites and energy
- metabolism
- physiological process
|
| Component |
| — |
|
| Enzyme 1 General Function |
Secondary metabolites biosynthesis, transport and catabolism |
| Enzyme 1 Specific Function |
Not Available |
| Enzyme 1 Pathways |
Not Available |
| Enzyme 1 Reactions |
Not Available |
| Enzyme 1 Pfam Domain Function |
|
| Enzyme 1 Signals |
|
| Enzyme 1 Transmembrane Regions |
|
| Enzyme 1 Essentiality |
Not Available |
| Enzyme 1 GenBank ID Protein |
55665524  |
| Enzyme 1 UniProtKB/Swiss-Prot ID |
Q5VTT0  |
| Enzyme 1 UniProtKB/Swiss-Prot Entry Name |
Q5VTT0_HUMAN  |
| Enzyme 1 PDB ID |
Not Available |
| Enzyme 1 Cellular Location |
Not Available |
| Enzyme 1 Gene Sequence |
>313 bp
ATGGAACTAATTTCCCCAACAGTGATTATAATCCTGGGTTGCCTTGCTCTGTTCTTACTC
CTTCAGCGGAAGAATTTGCGTAGACCCCCGTGCATCAAGGGCTGGATTCCTTGGATTGGA
GTTGGATTTGAGTTTGGGAAAGCCCCTCTAGAATTTATAGAGAAAGCAAGAATCAAGTAT
GGACCAATATTTACAGTCTTTGCTATGGGAAACCGAATGACCTTTGTTACTGAAGAAGAA
GGAATTAATGTGTTTCTAAAATCCAAAAAAGTAGATTTTGAACTAGCAGTGCAAAATATC
GTTTATCGTACAG
|
| Enzyme 1 GenBank Gene ID |
AL591242  |
| Enzyme 1 GeneCard ID |
CYP39A1  |
| Enzyme 1 GenAtlas ID |
CYP39A1  |
| Enzyme 1 HGNC ID |
HGNC:17449  |
| Enzyme 1 Chromosome Location |
6 |
| Enzyme 1 Locus |
6p21.1-p11.2 |
| Enzyme 1 SNPs |
SNPJam Report  |
| Enzyme 1 General References |
Not Available |
| Enzyme 1 Metabolite References |
Not Available |
|
Enzyme 2
[top]
|
| Enzyme 2 ID |
10660 |
| Enzyme 2 Name |
Cytochrome P450 46A1 |
| Enzyme 2 Synonyms |
- Cholesterol 24-hydroxylase
- CH24H
|
| Enzyme 2 Gene Name |
CYP46A1 |
| Enzyme 2 Protein Sequence |
>Cytochrome P450 46A1
MSPGLLLLGSAVLLAFGLCCTFVHRARSRYEHIPGPPRPSFLLGHLPCFWKKDEVGGRVL
QDVFLDWAKKYGPVVRVNVFHKTSVIVTSPESVKKFLMSTKYNKDSKMYRALQTVFGERL
FGQGLVSECNYERWHKQRRVIDLAFSRSSLVSLMETFNEKAEQLVEILEAKADGQTPVSM
QDMLTYTAMDILAKAAFGMETSMLLGAQKPLSQAVKLMLEGITASRNTLAKFLPGKRKQL
REVRESIRFLRQVGRDWVQRRREALKRGEEVPADILTQILKAEEGAQDDEGLLDNFVTFF
IAGHETSANHLAFTVMELSRQPEIVARLQAEVDEVIGSKRYLDFEDLGRLQYLSQVLKES
LRLYPPAWGTFRLLEEETLIDGVRVPGNTPLLFSTYVMGRMDTYFEDPLTFNPDRFGPGA
PKPRFTYFPFSLGHRSCIGQQFAQMEVKVVMAKLLQRLEFRLVPGQRFGLQEQATLKPLD
PVLCTLRPRGWQPAPPPPPC
|
| Enzyme 2 Number of Residues |
500 |
| Enzyme 2 Molecular Weight |
56822 |
| Enzyme 2 Theoretical pI |
Not Available |
| Enzyme 2 GO Classification |
| Function |
- binding
- catalytic activity
- cation binding
- heme binding
- ion binding
- iron ion binding
- monooxygenase activity
- oxidoreductase activity
- tetrapyrrole binding
- transition metal ion binding
|
| Process |
- cellular metabolism
- electron transport
- generation of precursor metabolites and energy
- metabolism
- physiological process
|
| Component |
| — |
|
| Enzyme 2 General Function |
Secondary metabolites biosynthesis, transport and catabolism |
| Enzyme 2 Specific Function |
Involved in the turnover of cholesterol. It converts cholesterol into 24S-hydroxycholesterol and, to a lesser extent, 25-hydroxycholesterol |
| Enzyme 2 Pathways |
Not Available |
| Enzyme 2 Reactions |
- Cholesterol + H+ + Nicotinamide adenine dinucleotide phosphate - reduced + O2 --> H2O + Nicotinamide adenine dinucleotide phosphate + 24-Hydroxycholesterol
|
| Enzyme 2 Pfam Domain Function |
|
| Enzyme 2 Signals |
|
| Enzyme 2 Transmembrane Regions |
|
| Enzyme 2 Essentiality |
Not Available |
| Enzyme 2 GenBank ID Protein |
5257114  |
| Enzyme 2 UniProtKB/Swiss-Prot ID |
Q9Y6A2  |
| Enzyme 2 UniProtKB/Swiss-Prot Entry Name |
CP46A_HUMAN  |
| Enzyme 2 PDB ID |
Not Available |
| Enzyme 2 Cellular Location |
Not Available |
| Enzyme 2 Gene Sequence |
Not Available |
| Enzyme 2 GenBank Gene ID |
AF094480  |
| Enzyme 2 GeneCard ID |
Not Available |
| Enzyme 2 GenAtlas ID |
CYP46A1  |
| Enzyme 2 HGNC ID |
HGNC:2641  |
| Enzyme 2 Chromosome Location |
Not Available |
| Enzyme 2 Locus |
Not Available |
| Enzyme 2 SNPs |
SNPJam Report  |
| Enzyme 2 General References |
- Lund EG, Guileyardo JM, Russell DW: cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7238-43. [PubMed
]
|
| Enzyme 2 Metabolite References |
Not Available |